CHEN CHING-SHIH has a total of 20 patent applications. Its first patent ever was published in 2004. It filed its patents most often in United States. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and measurement are BIOCRYST PHARM INC, TEVA PHARMACEUTICALS USA INC F and ORE PHARMACEUTICALS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 20 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Measurement | |
#4 | Biotechnology |
# | Name | Total Patents |
---|---|---|
#1 | Chen Ching-Shih | 20 |
#2 | Kulp Samuel K | 6 |
#3 | Wang Dasheng | 5 |
#4 | Chiu Hao-Chieh | 3 |
#5 | Weng Jing-Ru | 2 |
#6 | Schlesinger Larry S | 2 |
#7 | Gunn John S | 2 |
#8 | Shaw Arthur Y | 1 |
#9 | Kulp Samuel | 1 |
#10 | Muthusamy Natarajan | 1 |
Publication | Filing date | Title |
---|---|---|
US2014031388A1 | Akt inactivation by tocopheryl derivatives | |
US2012136063A1 | FTY720-derived anticancer agents | |
US2010267673A1 | Protein phosphatase 2A-activating agents | |
US2011054002A1 | Alkyl indole-3-carbinol-derived antitumor agents | |
US2012108823A1 | Anti-francisella agents | |
US2006142368A1 | Compounds and methods for inducing apoptosis in proliferating cells | |
US2006079566A1 | PDK-1/Akt signaling inhibitors |